Movatterモバイル変換


[0]ホーム

URL:


Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
Thehttps:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

NIH NLM Logo
Log inShow account info
Access keysNCBI HomepageMyNCBI HomepageMain ContentMain Navigation
pubmed logo
Advanced Clipboard
User Guide

Full text links

Elsevier Science full text link Elsevier Science
Full text links

Actions

Share

.2000 Jan;2(1):25-31.
doi: 10.1016/s1286-4579(00)00289-6.

Current epidemiology of human plague in Madagascar

Affiliations
Free article

Current epidemiology of human plague in Madagascar

S Chanteau et al. Microbes Infect.2000 Jan.
Free article

Abstract

From 1996 to 1998, 5,965 patients with suspected plague were identified in 38 districts of Madagascar (40% of the total population are exposed). Using standard bacteriology, 917 of them were confirmed or presumptive (C + P) cases. However, more than 2,000 plague cases could be estimated using F1 antigen assay. Two out of the 711 Yersinia pestis isolates tested were resistant to chloramphenicol and to ampicillin (both isolates found in the harbour of Mahajanga). Urban plague (Mahajanga harbour and Antananarivo city) accounted for 37.4% of the C + P cases. Bubonic plague represented 97.2% of the cases, and the lethality rate was still high (20%). In comparing the exposed population, plague was more prevalent in males (M:F sex ratio 1.3:1) and patients under 20 years (2.7% babies under two years). Buboes were mainly localised in the inguinal/femoral regions (55.8%). The epidemiological risk factors are discussed.

PubMed Disclaimer

Similar articles

  • Epidemiologic features of four successive annual outbreaks of bubonic plague in Mahajanga, Madagascar.
    Boisier P, Rahalison L, Rasolomaharo M, Ratsitorahina M, Mahafaly M, Razafimahefa M, Duplantier JM, Ratsifasoamanana L, Chanteau S.Boisier P, et al.Emerg Infect Dis. 2002 Mar;8(3):311-6. doi: 10.3201/eid0803.010250.Emerg Infect Dis. 2002.PMID:11927030Free PMC article.
  • Epidemiological characteristics of an urban plague epidemic in Madagascar, August-November, 2017: an outbreak report.
    Randremanana R, Andrianaivoarimanana V, Nikolay B, Ramasindrazana B, Paireau J, Ten Bosch QA, Rakotondramanga JM, Rahajandraibe S, Rahelinirina S, Rakotomanana F, Rakotoarimanana FM, Randriamampionona LB, Razafimbia V, De Dieu Randria MJ, Raberahona M, Mikaty G, Le Guern AS, Rakotonjanabelo LA, Ndiaye CF, Rasolofo V, Bertherat E, Ratsitorahina M, Cauchemez S, Baril L, Spiegel A, Rajerison M.Randremanana R, et al.Lancet Infect Dis. 2019 May;19(5):537-545. doi: 10.1016/S1473-3099(18)30730-8. Epub 2019 Mar 28.Lancet Infect Dis. 2019.PMID:30930106Free PMC article.
  • Urban epidemic of bubonic plague in Majunga, Madagascar: epidemiological aspects.
    Boisier P, Rasolomaharo M, Ranaivoson G, Rasoamanana B, Rakoto L, Andrianirina Z, Andriamahefazafy B, Chanteau S.Boisier P, et al.Trop Med Int Health. 1997 May;2(5):422-7.Trop Med Int Health. 1997.PMID:9217697
  • Plague.
    Dennis DT, Chow CC.Dennis DT, et al.Pediatr Infect Dis J. 2004 Jan;23(1):69-71. doi: 10.1097/01.inf.0000106918.18570.dd.Pediatr Infect Dis J. 2004.PMID:14743050Review.No abstract available.
  • [The plague: An overview and hot topics].
    Galy A, Loubet P, Peiffer-Smadja N, Yazdanpanah Y.Galy A, et al.Rev Med Interne. 2018 Nov;39(11):863-868. doi: 10.1016/j.revmed.2018.03.019. Epub 2018 Apr 5.Rev Med Interne. 2018.PMID:29628173Review.French.
See all similar articles

Cited by

See all "Cited by" articles

Publication types

MeSH terms

Substances

Related information

LinkOut - more resources

Full text links
Elsevier Science full text link Elsevier Science
Cite
Send To

NCBI Literature Resources

MeSHPMCBookshelfDisclaimer

The PubMed wordmark and PubMed logo are registered trademarks of the U.S. Department of Health and Human Services (HHS). Unauthorized use of these marks is strictly prohibited.


[8]ページ先頭

©2009-2025 Movatter.jp